← Eichor
Condition: Ctdna Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Ctdna

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After NAC in TNBC
Phase 2 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT04501523ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases
Phase N/A · 16 location(s) · GERCOR - Multidisciplinary Oncology Cooperative Group · NCT05787197ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC
Phase N/A · 1 location(s) · Fang Wu · NCT05198154A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Te
Phase 2 · 48 location(s) · AbbVie · NCT07023289RESPONSE: Colorectal Cancer Survivors' Follow-up Care - Now Digital and Need-based
NA · 9 location(s) · University of Aarhus · NCT06614647Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
NA · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT07025785Sweden Cancerome Analysis Network - Breast Recurrence (SCAN-B-rec)
Phase N/A · 2 location(s) · Lund University Hospital · NCT03758976ctDNA-guided Treatment Decision-making
Phase 2 · 1 location(s) · Fudan University · NCT07394218European Project for ctDNA Detection as a Biomarker for Non-invasive Therapy Monitoring in Paediatric Classical Hodgkin
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07356882The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer
NA · 4 location(s) · Thomas Jefferson University · NCT05502523EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations
NA · 6 location(s) · Dana-Farber Cancer Institute · NCT06716580Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy
Phase 2 · 1 location(s) · Vanderbilt-Ingram Cancer Center · NCT05770531Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast Cancer
Phase N/A · 1 location(s) · Julia Foldi · NCT06666439A Predictive Model for Recurrence of Colorectal Cancer Based on Multi-omics of Portal Vein Blood
Phase N/A · 1 location(s) · Peking University Shougang Hospital · NCT06524245Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)
NA · 13 location(s) · Institut Curie · NCT06225505GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Colorectal Cancer
Phase N/A · 15 location(s) · Claus Lindbjerg Andersen · NCT06111105Evaluating Novel Therapies in ctDNA Positive GI Cancers
Phase 3 · 3 location(s) · Georgetown University · NCT05482516Clinical Research of Drug Holiday Based on MRD Detection in GIST Patients at High Risk of Recurrence
Phase N/A · 1 location(s) · Peking University People's Hospital · NCT05867901ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST
Phase 2 · 1 location(s) · University of Miami · NCT05366816A Prospective Cohort Study on Colorectal Cancer Screening in Community Population
Phase N/A · 1 location(s) · Singlera Genomics Inc. · NCT05485077Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper
Phase N/A · 1 location(s) · RenJi Hospital · NCT05595408Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Canc
Phase N/A · 26 location(s) · AstraZeneca · NCT07052578Safety and Efficacy of Early Second Infusion of Axi-cel Based on ctDNA for R/R Large B - Cell Lymphoma
Phase 1/Phase 2 · 1 location(s) · Zhujiang Hospital · NCT06902012Clinical Utility of ctDNA in Detecting Resistance Mechanisms and Delivering Precision Medicine to Cancer Patients
NA · 1 location(s) · Royal Marsden NHS Foundation Trust · NCT07673861Impact of Radiotherapy on ctDNA in Patients With Hepatocellular Carcinoma
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT06885879Application Research of Methylation Markers in Early-stage Lung Cancer Patients Treated With Co-ablation System Therapy
Phase N/A · 1 location(s) · Beijing Haidian Hospital · NCT07257471ctDNA Monitoring in Early Breast Cancer
Phase N/A · 1 location(s) · Geneplus-Beijing Co. Ltd. · NCT04353557Use of Ctdna in Patients With Gastrointestinal Tract Tumors
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06202131Serial ctDNA and Molecular Residual Disease Monitoring in Neuroblastoma
Phase N/A · 1 location(s) · Sun Yat-sen University · NCT07516678Exploration of Adaptive Antitumoral Immune Cells Through Lymphapheresis in Cancer Patients : ALCYTA
NA · 2 location(s) · Institut Curie · NCT05354765
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.